{"id":32780,"date":"2023-06-12T07:00:00","date_gmt":"2023-06-12T05:00:00","guid":{"rendered":"https:\/\/www.ipsen.com\/press-releases\/ipsen-to-present-new-data-on-clinical-outcomes-and-patient-validation-tools-from-growing-rare-liver-disease-portfolio-at-easl-2023-5\/"},"modified":"2023-06-12T08:45:10","modified_gmt":"2023-06-12T06:45:10","slug":"ipsen-to-present-new-data-on-clinical-outcomes-and-patient-validation-tools-from-growing-rare-liver-disease-portfolio-at-easl-2023","status":"publish","type":"press_release","link":"https:\/\/d3glparxwv1yl3.cloudfront.net\/press-releases\/ipsen-to-present-new-data-on-clinical-outcomes-and-patient-validation-tools-from-growing-rare-liver-disease-portfolio-at-easl-2023\/","title":{"rendered":"Ipsen to present new data on clinical outcomes and patient validation tools from growing rare liver disease portfolio at EASL 2023"},"content":{"rendered":"